Rubius Therapeutics (RUBY) Financials

$0.06

$0.04 (171.43%)

As on 29-Dec-2023 15:49EDT

Market cap

$5 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	127.25	194.62	166.45	169.60	91.66	43.26
Operating Profit (EBIT)	-178.45	-194.62	-166.45	-169.60	-91.66	-43.26
Other Income	--	4.50	2.90	8.73	2.93	--
Profit before Tax	-179.67	-196.55	-167.73	-163.46	-89.20	-43.85
Provision for Tax	51.20	-7.72	-5.69	-3.00	2.93	0.31
Profit after Tax (Net Income)	-230.86	-188.82	-162.04	-160.46	-89.20	-43.85
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-179.67	-196.55	-167.73	-163.46	-89.20	-44.50

Liabilities ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	15.13	178.78	141.56	274.21	393.01	-43.69
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.10	104.58	108.39	86.87	66.10	144.22
Current Liabilities	7.94	34.66	27.84	33.76	20.00	7.16
Total Liabilities	23.07	318.02	277.79	394.84	479.11	107.69

Assets ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	2.88	88.20	96.28	105.58	64.70	2.70
Current Assets	20.20	229.82	181.51	289.27	414.41	104.99
Total Assets	23.07	318.02	277.79	394.84	479.11	107.69
Total Debt*	1.10	113.46	116.65	97.00	70.29	5.44
Net Current Assets	12.26	195.16	153.67	255.51	394.41	97.83

Cashflow ($ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	-150.14	-145.12	-127.65	-110.44	-58.34	-21.94
Cash Flow from Investing Activities	12.94	81.35	100.43	-132.64	-111.64	-2.25
Cash from Financing Activities	-75.47	198.45	26.48	27.29	374.83	121.69
Net Cash Inflow / Outflow	--	134.68	-0.73	-215.79	204.85	--

Financials Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-2.56	-2.10	-2.00	-2.01	-1.16	-5.02
Cash EPS ($)	-2.49	-2.01	-1.93	-1.98	-1.15	-4.97
Adjusted Book Value ($)	0.17	1.99	1.75	3.44	5.12	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-1.66	-1.61	-1.58	-1.39	-0.76	-2.51
Free Cash Flow per Share ($)	-1.72	-1.65	-1.64	-1.90	-0.95	-2.77

Profitability Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	-149.68	-68.61	-51.49	-38.46	-41.97	170.46
ROE (%)	-238.11	-117.89	-77.95	-48.10	-51.07	144.21
ROA (%)	-135.37	-63.38	-48.18	-36.72	-30.40	-75.81
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	-4,193.29	-5,583.74	-1,837.43	-3,042.12	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	8.31	-16.92	1.86	-85.03	-114.40	-293.38
Net Profit Growth (%)	-22.26	-16.53	-0.98	-79.90	-103.42	-298.03
EPS Growth (%)	-0.22	-0.05	0.01	-0.73	0.77	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	-0.07	-4.61	-3.79	-4.72	-13.84	--
Price / Book Value	1.04	4.87	4.34	2.76	3.14	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.02	-4.06	-3.45	-3.42	-9.96	--
Close Price ($)	0.18	9.68	7.59	9.50	16.08	--
High Price ($)	10.47	38.71	13.70	20.09	33.01	--
Low Price ($)	0.14	6.75	3.35	6.96	13.10	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	0.07	0.63	0.82	0.35	0.18	-0.12
Short term debt to equity ratio	0.07	0.05	0.06	0.04	0.01	-0.05
Current Ratio	2.54	6.63	6.52	8.57	20.72	14.67
Quick Ratio	--	--	--	--	--	--
Interest Coverage	-46.19	-30.25	-39.77	-65.48	-197.55	-138.36

Operating Efficiency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--